Lundbeck, Takeda sales and marketing update

Takeda and partner H. Lundbeck launched once-daily Brintellix vortioxetine in the U.S. to treat major depressive disorder (MDD). The wholesale acquisition cost is $218.10 for a 30-day supply. The Eur...